Krispy Kreme Donuts Overview
Zacks Rank #5 (Strong Sell) Krispy Kreme, Inc (DNUT) is adonut and sweet treat brand best-known for its signature Original Glazed doughnut. The company sells its products through brick-and-mortar locations. Additionally, Krispy Kreme sells through distribution outlets like grocery stores, gas stations, and major fast-food partners such as McDonald’s (MCD).
GLP-1 Use Surges
According to a recent Gallup poll, 11% of U.S. adults, or roughly 28 million people, are on GLP-1 weight-loss drugs such as Ozempic, Wegovy, and Mounjaro (up from 11% in 2024). Meanwhile, the Gallup poll does not include the many patients who have found alternative, cheaper paths to access unregulated versions of these drugs. GLP-1 drugs delay gastric emptying and signal fullness to the brain. According to Morgan Stanley, consumers remove confectionary, baked goods, and salty snacks from their diets. In fact, multiple studies suggest that sweet bakery purchases plunge nearly 10% once a patient starts these medications. Given that the majority of Krispy Kreme’s business relies on high calorie, sugary items, the rapid rise of GLP-1s is a significant long-term headwind for the company.
Krispy Kreme: Relative Weakness & Low Share Price
Krispy Kreme shares have chronically underperformed in both the short and long term. Over the past 5 years, DNUT shares have lost 78.8% of their value while the S&P 500 Index has gained 85.4%. With no end in sight to the bearish fundamentals, and little in the way of bullish catalysts, the persistent relative weakness should be a red flag for prospective investors.
Image Source: Zacks Investment Research
Additionally, Krispy Kreme’s stock currently trades at ~$3 per share. Stocks that trade for less than $10 per share typically deter institutional investors because they raise liquidity, scalability, and regulatory concerns. Because institutional investors have the deepest pockets and drive long-term moves, share price action is another problem for Krispy Kreme.
Krispy Kreme Doughnuts: A Consistent Underperformer
Wall Street analysts continue to hold a bearish outlook on Krispy Kreme. Zacks Consensus Analyst Estimates suggest that the company will deliver negative revenue growth through 2027.
Image Source: Zacks Investment Research
Meanwhile, the company’s earnings surprise history has been spotty. Krispy Kreme has missed Wall Street expectations in 8 of the past 19 quarters.
Image Source: Zacks Investment Research
An Ugly Balance Sheet
On top of tepid growth, high CAPEX, thin operating margins, and a heavy debt load plague Krispy Kreme. Its debt-to-equity ratio has nearly tripled since 2022.
Image Source: Zacks Investment Research
Bottom Line
Krispy Kreme faces severe long-term growth challenges as the rapid adoption of GLP-1 weight-loss medications directly impacts demand for sugary baked goods. Combined with chronic relative weakness, negative revenue growth, and soaring debt, DNUT shares remain an avoid.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power .
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
McDonald's Corporation (MCD): Free Stock Analysis Report
Krispy Kreme, Inc. (DNUT): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).